9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
105 hedge funds and large institutions have $94.2M invested in 9 Meters Biopharma in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 11 closing their positions.
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
33% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 21
15% more capital invested
Capital invested by funds: $81.7M → $94.2M (+$12.5M)
6% more funds holding
Funds holding: 99 → 105 (+6)
18% less call options, than puts
Call options by funds: $3.34M | Put options by funds: $4.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GTC
Ghost Tree Capital
New York
|
+$3.24M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$1.6M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.03M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$876K |
| 5 |
State Street
Boston,
Massachusetts
|
+$597K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.59M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.46M |
| 3 |
Two Sigma Advisers
New York
|
-$1.78M |
| 4 |
Renaissance Technologies
New York
|
-$1.44M |
| 5 |
Morgan Stanley
New York
|
-$1.28M |
NMTR Hedge Fund Activity: Q3 2021 in Review
105 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2021, worth a combined $94.2M — up 15% from $81.7M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new NMTR positions and 11 closed out — a net gain of 7 holders — while 28 added to existing stakes and 21 trimmed.
The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.24M. The largest seller was Millennium Management, cutting an estimated $2.59M.
- 105 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2021, up from 99 in Q2 2021.
- Funds reported $94.2M of 9 Meters Biopharma stock for Q3 2021, up 15% quarter-over-quarter.
- 18 funds opened new 9 Meters Biopharma positions in Q3 2021 and 11 closed out, a net change of +7 holders.
- The largest 9 Meters Biopharma buyer in Q3 2021 was Ghost Tree Capital, an estimated $3.24M added.
- The largest 9 Meters Biopharma seller in Q3 2021 was Millennium Management, an estimated $2.59M sold.
Based on aggregated 13F filings for Q3 2021.